Cargando…

Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection

Altered pharmacokinetics (PK) of hydrophilic antibiotics in critically ill patients is common, with possible consequences for efficacy and resistance. We aimed to describe ceftazidime population PK in critically ill patients with a proven or suspected Pseudomonas aeruginosa infection and to establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Werumeus Buning, Annabel, Hodiamont, Caspar J., Lechner, Natalia M., Schokkin, Margriet, Elbers, Paul W. G., Juffermans, Nicole P., Mathôt, Ron A. A., de Jong, Menno D., van Hest, Reinier M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224000/ https://www.ncbi.nlm.nih.gov/pubmed/34063815 http://dx.doi.org/10.3390/antibiotics10060612

Ejemplares similares

Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study
por: Zieck, Saskia E., et al.
Publicado: (2023)

The assessment of environmental and external cross‐contamination in preparing ready‐to‐administer cytotoxic drugs: a comparison between a robotic system and conventional manual production
por: Werumeus Buning, Annabel, et al.
Publicado: (2019)

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
por: Hodiamont, Caspar J., et al.
Publicado: (2022)

Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older
por: Franzese, Richard C., et al.
Publicado: (2021)

Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats
por: Feng, Yanfang, et al.
Publicado: (2016)

Impact of a vancomycin loading dose on the achievement of target vancomycin exposure in the first 24 h and on the accompanying risk of nephrotoxicity in critically ill patients
por: Hodiamont, C J, et al.
Publicado: (2021)

In Favor of Controlling Proven, but Not Probable, Causes of Cancer
por: Erren, Thomas C., et al.
Publicado: (2011)

Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports
por: Zhang, Xiao-Shan, et al.
Publicado: (2022)

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
por: Li, Jianguo, et al.
Publicado: (2018)

739. Prediction of Cefiderocol Pharmacokinetics and Probability of Target Attainment in Pediatric Subjects for Proposing Dose Regimens
por: Katsube, Takayuki, et al.
Publicado: (2019)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Correction to: Efficacy and Pharmacodynamic Target Attainment for Ceftazidime–Avibactam Off-Label Dose Regimens in Patients with Continuous or Intermittent Venovenous Hemodialysis: Two Case Reports
por: Zhang, Xiao-Shan, et al.
Publicado: (2022)

Diagnostic accuracy of procalcitonin in proven and clinically suspected systemic infection
por: Das, S, et al.
Publicado: (2012)

Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations
por: Sinkeler, Fleur S, et al.
Publicado: (2014)

Prevalence of Dietary Supplement Use in Patients with Proven or Suspected Cardiovascular Disease
por: Bin, Yu Sun, et al.
Publicado: (2011)

Intravenous Immunoglobulin Doesn’t Decrease Mortality for Suspected or Proven Sepsis in the Neonate
por: AlOmran, Abbas
Publicado: (2013)

Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study
por: Meng, Haiyang, et al.
Publicado: (2023)

In Favor of Controlling Proven, but Not Probable, Causes of Cancer: Landrigan et al. Respond
por: Landrigan, Philip J., et al.
Publicado: (2011)

Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021)

Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022)

Human Target Attainment Probabilities for Delafloxacin against Escherichia coli and Pseudomonas aeruginosa
por: Hoover, Randall, et al.
Publicado: (2017)

Beta-Lactam Probability of Target Attainment Success: Cefepime as a Case Study
por: Selig, Daniel J., et al.
Publicado: (2023)

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases
por: Angebault, Cécile, et al.
Publicado: (2016)

Population Pharmacokinetics and Probability of Target Attainment Analysis of Nadroparin in Different Stages of COVID-19
por: Piwowarczyk, Paweł, et al.
Publicado: (2023)

Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers
por: Edwina, Angela Elma, et al.
Publicado: (2023)

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
por: Leroy, Olivier, et al.
Publicado: (2016)

Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study
por: Bos, Jeannet C., et al.
Publicado: (2017)

Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem-Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases
por: Gatti, Milo, et al.
Publicado: (2022)

Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
por: Sidamo, Temesgen, et al.
Publicado: (2022)

Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
por: Al-Sadawi, Mohammed, et al.
Publicado: (2019)

Ceftazidime/avibactam for specified infections
Publicado: (2020)

Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients
por: de Winter, Brenda C. M., et al.
Publicado: (2009)

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases
por: Revankar, Sanjay G, et al.
Publicado: (2017)

Performance of Kiestra Total Laboratory Automation Combined with MS in Clinical Microbiology Practice
por: Mutters, Nico T., et al.
Publicado: (2014)

A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
por: Cristinacce, Andrew, et al.
Publicado: (2019)

Population Pharmacokinetic–Pharmacodynamic Modeling and Probability of Target Attainment Analysis of Rocuronium and Sugammadex in Children Undergoing Surgery
por: Grześkowiak, Małgorzata, et al.
Publicado: (2022)

All Roads Lead to Rome: Enhancing the Probability of Target Attainment with Different Pharmacokinetic/Pharmacodynamic Modelling Approaches
por: Khalid, Kashaf, et al.
Publicado: (2023)

Effects of immunotherapy on mortality in neonates with suspected or proven sepsis: a systematic review and network meta-analysis
por: Li, Yuhang, et al.
Publicado: (2019)

Probable Toxic Cause for Suspected Lychee-Linked Viral Encephalitis
por: Spencer, Peter S., et al.
Publicado: (2015)

Double threshold in bi- and multilingual contexts: preconditions for higher academic attainment in English as an additional language
por: Lechner, Simone, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9qquvgsajrcphbft312tlcptk3